Scienture Holdings, Inc. (SCNX)
Last updated: 2026-10-20 11:33:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Scienture Holdings, Inc. (SCNX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.07, with a market capitalization of $5.52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.81 to $65.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.52M | |
$3.31 | |
$238.75 | |
$2.81 | |
$2.92 | |
1.70K | |
193.05K | |
-- | |
$65.00 | |
$2.81 | |
-- | |
-- |
Scienture Holdings, Inc. (SCNX) Pre-Market Stock Price
Scienture Holdings, Inc. (SCNX) is trading at $3.07 in pre-market trading as of 2026-10-20 11:31:00, up 5.07% ($0.15) from the previous close of $2.92
Pre-market trading shows how investors are pricing SCNX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Scienture Holdings, Inc. (SCNX) 7-Day Stock Price Change
Over the past seven days, Scienture Holdings, Inc. (SCNX) moved from $3.76 to $3.07, representing a decline of 18.40% ($0.69).
The stock traded between $2.81 and $3.93 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 104.51 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
SCNX 52-Week Price Position
Position in Range: 0.4%
SCNX is currently trading at $3.07, placing it 0.4% of the way from its 52-week low of $2.81 to its 52-week high of $65.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Scienture Holdings, Inc. (SCNX)?
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Scienture Holdings, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Scienture Holdings, Inc. (SCNX) Stock on MEXC
Eligible investors can buy real shares of Scienture Holdings, Inc. (SCNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Scienture Holdings, Inc. (SCNX) stock price today?
2.Is SCNX stock going up or down today?
3.What is SCNX pre-market price?
4.What is SCNX after-hours price?
5.Is SCNX stock trading now?
6.Where does SCNX sit relative to its 52-week high and low?
7.What sector is Scienture Holdings, Inc. in?
8.What is Scienture Holdings, Inc.'s market capitalization and where is it listed?
9.How is SCNX valued in terms of P/E ratio and EPS?
10.Does Scienture Holdings, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SCNX Stock Calculator
Estimate the value between SCNX shares and USD.
SCNX Shares to USD
1.00 SCNX shares = 3.068 USD
Calculations are estimates based on the latest available price and are for reference only.


